Compared with the HFD group, the DAG group significantly downregulated the expression of lipogenic genes, including stearoyl‐CoA desaturase 1 (SCD1), fatty acid synthase (FASN), and acetyl‐CoA carboxylase 1 (ACC1) (p < 0.05), while significantly upregulating the expression of lipolytic gene hormone‐sensitive lipase (HSL) and fatty acid oxidation‐related genes, including CPT‐1 and PPAR‐α (p < 0.05), thereby ameliorating lipid metabolic disorders. The gene discussed is SCD; the disease is Disorder of lipid metabolism.